Current Clinical Trials
Currently we are conducting the following Clinical Trial(s):
- Narcolepsy Clinical Trial: Patients ages 18-65, with Narcolepsy. This study is looking at the effect of a new medicine on sleepiness in patients with Narcolepsy who have access to their previous test results confirming Narcolepsy. The study lasts about 5 weeks, with three sleep testing stays (overnight and the next day) with us. Patients may get active medicine or placebo. We pay $1700 for the subject’s time and expenses upon completing the study.
- Idiopathic Hypersomnia Open Label Clinical Trial with Double Blind Withdrawal: Patients age 18 or older, with Idiopathic Hypersomnia (IH). This study looks at the effect of a new medicine on sleepiness in patients with IH. This starts as an open-label study in which everyone gets medicine. Patients may stay on previous medicines for IH if they are still excessively sleepy on them. who have access to their previous test results confirming Narcolepsy. The study lasts about 14 weeks, with 5 office visits and several phone calls. If patients do well on this medicine, there is a 4 week period during which they may get medicine or placebo. Patients may get active medicine of placebo. We pay $950 for the subject’s time and expenses upon completing the study. At the end of the study, patients may join an open label extension study during which they get the medicine for sure for several months.
Clinical trials come and go, and they fill up fast.